Benzinga - Gainers
- Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
- ContraFect Corporation (NASDAQ: CFRX) gained 87% to $2.4693. ContraFect said first patient was dosed in the Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
- Hillstream BioPharma, Inc. (NASDAQ: HILS) jumped 56% to $1.10.
- TOP Financial Group Limited (NASDAQ: TOP) rose 53.7% to $10.33.
- U Power Limited (NASDAQ: UCAR) climbed 33.5% to $5.45 after declining around 27% on Wednesday.
- Atomera Incorporated (NASDAQ: ATOM) shares gained 23.6% to $6.45 after the company posted results for its first quarter. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
- OMNIQ Corp. (NASDAQ: OMQS) climbed 20.8% to $5.47.
- Vapotherm, Inc. (NYSE: VAPO) rose 19.4% to $0.5001.
- Helen of Troy Limited (NASDAQ: HELE) shares gained 19.1% to $97.39 after the company announced better-than-expected Q4 results.
- Nuburu, Inc. (NYSE: BURU) gained 19% to $1.13.
- Bel Fuse Inc. (NASDAQ: BELFB) rose 18.3% to $36.25 following better-than-expected quarterly results.
- Immuron Limited (NASDAQ: IMRN) gained 16.4% to $2.23.
- CXApp Inc. (NASDAQ: CXAI) climbed 16% to $10.74.
- Mainz Biomed N.V. (NASDAQ: MYNZ) gained 15.6% to $3.92.
- Accuray Incorporated (NASDAQ: ARAY) jumped 15% to $3.1050 after the company reported better-than-expected Q3 EPS and sales results.
- LianBio (NASDAQ: LIAN) rose 14.7% to $2.26. LianBio announced topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
- Meta Platforms, Inc. (NASDAQ: META) climbed 14.3% to $239.64 as the company reported better-than-expected Q1 results and also announced an increase in active users.
- Immix Biopharma, Inc. (NASDAQ: IMMX) gained 14.1% to $2.13 after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
- GRI Bio, Inc. (NASDAQ: GRI) gained 14.1% to $6.79.
- Goosehead Insurance, Inc (NASDAQ: GSHD) jumped 13.8% to $61.15 following upbeat quarterly results.
- Overstock.com, Inc. (NASDAQ: OSTK) rose 13.7% to $20.54 following strong quarterly results.
- Ardagh Metal Packaging S.A. (NYSE: AMBP) gained 13.5% to $3.93 following Q1 results.
- Materialise NV (NASDAQ: MTLS) gained 13% to $8.80 as the company posted upbeat Q1 results and named Koen Berges as CFO.
- Cimpress plc (NASDAQ: CMPR) jumped 12.4% to $48.72 following strong quarterly sales.
- Hasbro, Inc. (NASDAQ: HAS) gained 10.8% to $57.00 after the company reported better-than-expected Q1 sales results and reiterated FY23 adjusted EPS guidance above the estimate.
- Mangoceuticals, Inc (NASDAQ: MGRX) surged 10.7% to $1.3418 after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
- Getaround, Inc. (NYSE: GETR) climbed 9.9% to $0.4999. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.
- Kaiser Aluminum Corporation (NASDAQ: KALU) gained 9.7% to $63.82 following Q1 results.
- OpGen, Inc. (NASDAQ: OPGN) gained 6% to $0.88 after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.
- Baudax Bio, Inc. (NASDAQ: BXRX) fell 52.5% to $0.8406 after the company reported the pricing of $4 million public offering.
- Impinj, Inc. (NASDAQ: PI) dropped 35.2% to $87.71 after the company reported mixed Q1 results and issued weak guidance.
- 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) shares fell 31.1% to $14.18. 4DMT presented interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial in patients with wet AMD at ARVO 2023.
- Aspen Technology, Inc. (NASDAQ: AZPN) fell 25% to $173.76 after the company posted downbeat Q3 results and issued weak FY23 forecast.
- Mobileye Global Inc. (NASDAQ: MBLY) dropped 22% to $33.58 after the company lowered FY23 revenue guidance below estimates.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) fell 20.6% to $0.1206. Crown Electrokinetics recently issued a letter to shareholders.
- Satixfy Communications Ltd. (NYSE: SATX) dropped 19.8% to $0.8101.
- PROCEPT BioRobotics Corporation (NASDAQ: PRCT) fell 19.2% to $28.89 following wider-than-expected Q1 loss.
- Crocs, Inc. (NASDAQ: CROX) fell 18.5% to $120.35 after the company reported Q1 earnings results and after the company issued Q2 guidance.
- ETAO International Co., Ltd. (NASDAQ: ETAO) shares dropped 18.3% to $0.96 after gaining around 57% on Wednesday.
- NETGEAR, Inc. (NASDAQ: NTGR) dipped 18.1% to $13.77 following weak quarterly results.
- Ideanomics, Inc. (NASDAQ: IDEX) fell 17.2% to $0.0227 after dropping around 22% on Wednesday.
- Kuke Music Holding Limited (NYSE: KUKE) dropped 16.9% to $0.60.
- Wolfspeed, Inc. (NYSE: WOLF) fell 16.2% to $48.11 after the company issued weak Q4 guidance.
- Avinger, Inc. (NASDAQ: AVGR) fell 15.5% to $0.54.
- MaxLinear, Inc. (NYSE: MXL) dipped 15.5% to $24.78 after the company issued weak Q2 guidance.
- IN8bio, Inc. (NASDAQ: INAB) fell 13.3% to $1.6902. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
- H&E Equipment Services, Inc. (NASDAQ: HEES) declined 12% to $36.36 following Q1 results.
- Align Technology, Inc. (NASDAQ: ALGN) fell 11.7% to $312.85 after the company reported Q1 financial results and issued guidance.
- Opera Limited (NASDAQ: OPRA) dropped 11.6% to $10.04 following Q1 results.
- Sonic Automotive, Inc. (NYSE: SAH) gained 11.3% to $46.28 following weak quarterly results.
- American Rebel Holdings, Inc. (NASDAQ: AREB) shares fell 11% to $0.1371 after gaining around 14% on Wednesday.
- National Energy Services Reunited Corp. (NASDAQ: NESR) dipped 11% to $2.94 after the company announced it was not able to file its Annual Report on Form 20-F for its fiscal year ended December 31, 2021 with the SEC.
- Clearmind Medicine Inc. (NASDAQ: CMND) fell 10.5% to $0.62. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
- Morningstar, Inc. (NASDAQ: MORN) dropped 9.3% to $172.95 following Q1 results.
- AbbVie Inc. (NYSE: ABBV) dropped 8.5% to $147.95 after the company reported Q1 financial results and issued FY23 guidance.
- Mobiquity Technologies, Inc. (NASDAQ: MOBQ) fell 8.4% to $0.1718 after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
- STMicroelectronics N.V. (NYSE: STM) shares dropped 8.4% to $42.37 after reporting Q1 results.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.